Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07164443
What this trial is testing

Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC 1,203
Testing effectiveness (Phase 2)UnknownNCT02775539
What this trial is testing

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

Who this might be right for
Pulmonary HypertensionMirabegronHeart Failure+1 more
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 80
Testing effectiveness (Phase 2)Study completedNCT01576172
What this trial is testing

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7
National Cancer Institute (NCI) 159
Not applicableStudy completedNCT02471469
What this trial is testing

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Radboud University Medical Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600701
What this trial is testing

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaRefractory Lung Non-Small Cell Carcinoma+1 more
National Cancer Institute (NCI) 53
Not applicableEnded earlyNCT01076751
What this trial is testing

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Prostatic Neoplasms
Sanofi 82
Testing effectiveness (Phase 2)Study completedNCT01972217
What this trial is testing

Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 158
Not applicableNot Yet RecruitingNCT07186868
What this trial is testing

QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

Who this might be right for
Recurrent Cervical CancerMetastatic Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07651618
What this trial is testing

A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Metastatic
East Metropolitan Health Service, Australia 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07545213
What this trial is testing

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

Who this might be right for
Non-small Cell Lung CancerEGFR Mutant Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 27
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)WithdrawnNCT04781374
What this trial is testing

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaCastration-resistant Prostate CancerProstate Cancer+1 more
Beth Israel Deaconess Medical Center
Not applicableStudy completedNCT02374996
What this trial is testing

Pharmacoepigenetics of Bipolar Disorder Treatment

Who this might be right for
Antipsychotic AgentsBipolar Disorder
Wayne State University 40
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT02280252
What this trial is testing

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

Who this might be right for
Breast Cancer
NYU Langone Health 69
Large-scale testing (Phase 3)Study completedNCT01308567
What this trial is testing

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 1,168
Testing effectiveness (Phase 2)Study completedNCT02854436
What this trial is testing

An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 289
Large-scale testing (Phase 3)Ended earlyNCT02962388
What this trial is testing

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Who this might be right for
Essential Thrombocythemia
French Innovative Leukemia Organisation 13
Not applicableNo Longer AvailableNCT03706573
What this trial is testing

Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer

Who this might be right for
HR+ Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT06492122
What this trial is testing

Study With [225Ac]Ac-FL-020 in mCRPC Participants

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Full-Life Technologies UK Limited 50
Next Page